10 December 2008 15:54 [Source: ICIS news]
PARIS (ICIS news)--German chemicals major BASF criticised on Wednesday the decision by the European Food Safety Authority (EFSA) to delay its opinion on whether the genetically modified (GM) starch potato is safe for commercial use.
EFSA said today that it would not complete its opinion on nptII, an antibiotic resistant marker gene used in Amflora, by 15 December as previously announced.
The European Commission has granted EFSA an extension to 31 March 2009.
“This delay means that commercial cultivation of Amflora will not be possible in 2009 and will deprive European farmers and the potato starch industry of €100-200m in income,” said Stefan Marcinowski, a member of BASF’s board of executive directors.
“There is no scientific evidence that questions the safety of Amflora,” he added, blaming the delay on “European commissioners’ political motivations”.
The Commission failed to approve Amflora in May and asked EFSA to carry out a fifth safety assessment on the gene, provoking BASF to file a court action against the Commission for delaying the approval process.
To discuss issues facing the chemical industry go to ICIS connect
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|
Asian Chemical Connections